Form 4: Insmed Inc. Chief Legal Officer Michael Alexander Smith Reports Stock Transaction
SEC Form 4 Filing
Chief Legal Officer Michael Alexander Smith reports a transaction involving Insmed Inc. common stock related to tax withholding on vesting Restricted Stock Units.
Summary
- On July 8, 2024, Michael Alexander Smith, Chief Legal Officer of Insmed Inc., reported a transaction involving the company's common stock.
- 730 shares were disposed of to satisfy tax withholding requirements on the vesting of Restricted Stock Units (RSUs).
- The price per share for the transaction was $70.05, representing the closing price of the common stock on the vesting date.
- Following the transaction, Smith beneficially owns 88,727 shares of Insmed Inc., which includes 629 shares acquired through the company's 2018 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction related to tax obligations. It doesn't indicate any positive or negative sentiment towards the company's performance or future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a standard practice of withholding shares to cover tax obligations upon the vesting of RSUs.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of the stock transaction (disposal of shares for tax withholding). |
| 07/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.